ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche: FTC Requests More Information On Illumina Offer

DOW JONES NEWSWIRES U.S. regulators have asked Roche Holding AG (ROG.VX, RHHBY) for additional information about its proposed takeover of Illumina Inc. (ILMN), the drug maker said Tuesday. The Federal Trade Commission's request reflects antitrust concerns about Roche's microarray business and would delay any acquisition another 10 days after Roche complies with the second request under U.S. law. Roche is still working to complete its hostile takeover of Illumina, which continues to oppose the Swiss company's offer as inadequate. Illumina makes machines that use blood or tissue samples to decode a person's entire genetic makeup in about a week--a process known as DNA sequencing. Shares of the takeover target closed at $50.34 Tuesday and were unchanged after hours. Roche's cash offer values the company at $44.50 a share. -By Drew FitzGerald, Dow Jones Newswires; 212-416-2909; Andrew.FitzGerald@dowjones.com

Stock News for Illumina (ILMN)
DateTimeHeadline
03/23/201714:15:53Statement of Changes in Beneficial Ownership (4)
03/08/201719:59:00MLL Münchner Leukämielabor wählt IBM Watson und Illumina für For...
03/08/201716:34:00Le Munich Leukemia Laboratory lance avec IBM Watson et Illumina...
03/08/201703:52:00CORRECTING & REPLACING Munich Leukemia Laboratory Selects IBM...
03/08/201702:00:00Munich Leukemia Laboratory Selects IBM Watson & Illumina for...
03/07/201708:00:00OPKO Subsidiary GenPath Women’s Health Announces the Availability o...
03/01/201708:06:13Current Report Filing (8-k)
02/28/201709:30:00OPKO Health’s GeneDx Announces Participation in Illumina’s iHo...
02/28/201709:00:00Illumina Announces the iHope Network, an Expansion of Its iHope...
02/21/201713:21:21Current Report Filing (8-k)
02/21/201706:30:00Illumina to Webcast Live Presentation at the Cowen and Company...
02/20/201709:00:00Illumina Names John W. Thompson to Its Board of Directors, Bringing...
02/14/201710:54:35Statement of Ownership (sc 13g)
02/14/201706:10:26Annual Report (10-k)
02/13/201717:26:21Amended Statement of Ownership (sc 13g/a)
02/13/201708:33:01Current Report Filing (8-k)
02/10/201715:57:00Statement of Changes in Beneficial Ownership (4)
02/10/201715:34:03Amended Statement of Ownership (sc 13g/a)
01/31/201716:32:30Current Report Filing (8-k)
01/31/201716:05:00Illumina Reports Full Financial Results for Fourth Quarter and...

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US